The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial

Overview of attention for article published in Diabetology & Metabolic Syndrome, July 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 59 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes: Committee papers

Cited by National Institute for Health and Care Excellence on 23 Dec 2015

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.